These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Sankaranarayanan R, Wesley R, Thara S, Dhakad N, Chandralekha B, Sebastian P, Chithrathara K, Parkin DM, Nair MK. Int J Cancer; 2003 Sep 01; 106(3):404-8. PubMed ID: 12845681 [Abstract] [Full Text] [Related]
25. A retrospective study of cervical screening in women under 25 years (2005-2009). Ali AA, Richardson D, Hill N. Arch Gynecol Obstet; 2013 Apr 01; 287(4):765-9. PubMed ID: 23183714 [Abstract] [Full Text] [Related]
29. Outcome of women with inadequate cervical smears followed up for five years. Hock YL, Ramaiah S, Wall ES, Harris AM, Marston L, Marshall J, Kendall K, Teale A. J Clin Pathol; 2003 Aug 01; 56(8):592-5. PubMed ID: 12890808 [Abstract] [Full Text] [Related]
31. The development of the referral outcome diagram and an analysis of laboratory cancer detection rates in the English NHS cervical screening programme--is there an optimum level of detection of CIN 1 and CIN 2 lesions? Blanks RG. Cytopathology; 2008 Aug 01; 19(4):244-53. PubMed ID: 18476989 [Abstract] [Full Text] [Related]
32. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme. Blanks RG, Moss SM, Coleman DA, Addou S, Swerdlow AJ. Cytopathology; 2009 Jun 01; 20(3):154-60. PubMed ID: 19207309 [Abstract] [Full Text] [Related]
33. [Colposcopy of abnormal transformation zone]. Rokita W. Wiad Lek; 2006 Jun 01; 59(7-8):486-9. PubMed ID: 17209344 [Abstract] [Full Text] [Related]
35. The contribution of endocervical smears to cervical cancer detection. Shingleton HM, Gore H, Austin JM, Littleton HJ, Straugin JM. Acta Cytol; 1975 Jun 01; 19(3):261-4. PubMed ID: 1096515 [Abstract] [Full Text] [Related]
37. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. Leinonen M, Nieminen P, Kotaniemi-Talonen L, Malila N, Tarkkanen J, Laurila P, Anttila A. J Natl Cancer Inst; 2009 Dec 02; 101(23):1612-23. PubMed ID: 19903804 [Abstract] [Full Text] [Related]